Impel Neuropharma Inc (IMPL) Stock
IMPL is no longer traded. Impel Neuropharma was delisted from the Nasdaq in February 2024.
Prices on this page are historical; the last trade was February 16, 2024 at $0.02.
Impel Neuropharma stock price history
IMPL final trading statistics
- Final close
- $0.02
- Final trading day
- Feb 16, 2024
- Market cap at delisting
- $5.76M
- Shares outstanding
- 23.90M
- Final 52-week range
- $0.01 – $2.87
- Avg. volume (final 3 mo.)
- 792,318
- All-time high (split-adj.)
- $26.13 · Aug 2021
- All-time low (split-adj.)
- $0.01 · Feb 2024
- Return since IPO
- -99.9%
- Beta
- 1.17
- Book value / share
- -$3.87
- Price / book
- -0.00
Impel Neuropharma annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $20.99M | -$74.3M | -$2.16 |
| FY2022 | $12.65M | -$129.4M | -$4.54 |
| FY2021 | $668.0K | -$76.5M | -$3.95 |
| FY2020 | $0.00 | -$45.8M | -$0.73 |
| FY2019 | $0.00 | -$41.9M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Impel Neuropharma Inc
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. The company was incorporated in 2008 and is headquartered in Seattle, Washington. On December 19, 2023, Impel Pharmaceuticals Inc, along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.
Impel Neuropharma stock FAQ
What happened to Impel Neuropharma stock?
Impel Neuropharma stock was delisted from the Nasdaq. Its final close was $0.02 on February 16, 2024.
Is IMPL stock still trading?
No. IMPL was delisted from the Nasdaq in February 2024 and no longer trades on a U.S. exchange.
What was the last price of IMPL stock?
IMPL closed at $0.02 on its final trading day, February 16, 2024, for a market value of about $5.76M.
What were Impel Neuropharma's revenue and earnings in its last full fiscal year?
Impel Neuropharma reported revenue of $20.99M and net income of -$74.3M in fiscal 2023, its last full year as a public company.
When did Impel Neuropharma go public?
Impel Neuropharma Inc stock began trading on April 23, 2021.